[11C]flumazenil-PET: De benzodiazepinereceptor in beeld

Translated title of the contribution: [11C]flumazenil-PET. An image of the benzodiazepine receptor

Y. P. Dijstelbloem, H. Verschoor, A. D. Windhorst, G. Luurtsema, A. A. Lammertsma, E. J F Franssen

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)


Positron emission tomography (PET) is an imaging technology with clinical applications in diagnostics and pharmacological research. [11C]flumazenil is a PET-radiopharmaceutical suitable for identification of binding sites for benzodiazepines in the brain. [11C]flumazenil is a radiopharmaceutical with a short shelf-life, due to the short physical half-life of the carbon-II isotope (20 minutes). For this reason, a rapid radionuclide production, chemical synthesis, formulation, quality control and release procedure are required. PET using [11C]flumazenil is clinically applied to localise epileptic foci in the brain. In research, it is used to investigate changes in benzodiazepine receptor concentration and drug binding to receptors.

Translated title of the contribution[11C]flumazenil-PET. An image of the benzodiazepine receptor
Original languageDutch
Pages (from-to)416-422
Number of pages7
JournalPharmaceutisch Weekblad
Issue number12
Publication statusPublished - 21 Mar 2003


  • Drug compounding
  • Emission-computed
  • Flumazenil
  • Radioisotopes
  • Receptors, GABA-A
  • Tomography

Cite this